General News | Dec. 17, 2013

Lupus Foundation of America Marks Tenth Anniversary of Lupus Now® Magazine

The Lupus Foundation of America celebrates the 10th anniversary of its national magazine, Lupus Now®, the only national publication devoted to addressing the complexities of living with lupus. The 10th anniversary issue introduces a new format with more concise reporting on advances in lupus research and treatment, wellness features, clinical updates, and inspiring personal stories.

Magazine | Dec. 09, 2013

Lupus Now Celebrates Its Tenth Anniversary

Lupus Now magazine editor Jenny Thorn Palter and Lupus Foundation of America President & CEO Sandra C. Raymond talk about the tenth anniversary of the only national publication devoted to helping people deal with the complexities of lupus.

Research News | Dec. 05, 2013

Cancer Risk May Be Higher Among Young Patients with Lupus

Children with lupus may have a higher risk for developing cancer – especially blood cancers such as non-Hodgkin’s lymphoma and leukemia – compared to children without lupus.

Blog | Dec. 05, 2013

The Value of Your Donation

By investing in the Lupus Foundation of America, your donation, no matter the gift size, is being put to work. Read more from Donna Grogan, Vice President of Development and Fundraising.

Blog | Dec. 04, 2013

Access to Prescription Drugs is a Must

Kim Cantor, Lupus Foundation of America’s Senior Director of Public Policy and Government Relations, discusses the Foundation’s Medicare for Patients RX (MAPRx) Coalition

Podcasts | Nov. 07, 2013

Human Mesenchymal Stem Cells as a Potential Therapy for Lupus

Dr. Gary Gilkeson of the Medical University of South Carolina discusses his Lupus Foundation of America funded study on the potential use of human mesenchymal stem cells as a therapy for lupus.

Blog | Nov. 05, 2013

Why Are Treatments That Were Developed For Malaria Now Widely Used for Lupus?

In her Expert Column, Dr. Joan T. Merrill, Medical Director, explains why antimalarial medicines are now used to treat lupus.

Research News | Oct. 30, 2013

New Research Gives Insight for Improving Future Lupus Clinical Trials

A new study that analyzed lupus treatment data from past global clinical trials suggests that when testing new drugs in combination with other background therapies, clinical trials should be designed to account for the effects that initial disease activity and background drug treatment have been shown to have on planned endpoints, like response and flare rates.